Alle Storys
Folgen
Keine Story von LifeWatch AG mehr verpassen.

LifeWatch AG

DGAP-Adhoc: LifeWatch AG:

LifeWatch AG  / Key word(s): Agreement

16.10.2014 23:07

Release of an ad hoc announcement pursuant to Art. 53 KR
---------------------------------------------------------------------------

Press Release

LifeWatch Services, Inc. and LifeWatch AG announces the reinstatement of
Cigna Corporation's coverage of mobile cardiac monitoring services

Neuhausen am Rheinfall/Switzerland, October 16, 2014 - LifeWatch AG (SIX
Swiss Exchange: LIFE), a leading provider of medical solutions in remote
cardiac monitoring, announces that Cigna Corporation has reinstated
coverage of the Ambulatory Cardiac Telemetry (ACT) service provided by its
subsidiary, LifeWatch Services, Inc.

The coverage is retroactively effective as of June 15, 2014 and applies to
all Cigna affiliated entities.

In addition, the parties entered into a confidential settlement agreement
and LifeWatch Services, Inc. will be dismissing its pending case filed in
the U.S. District Court for the Eastern District of Pennsylvania.


For further questions:

LifeWatch AG
c/o Dynamics Group, Philippe Blangey / Doris Rudischhauser
Phone: +41 43 268 32 35
E-mail:  investor-relations@lifewatch.com

About LifeWatch AG:
LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed on SIX
Swiss Exchange (LIFE), Switzerland, is a leading healthcare technology and
solution company, specializing in advanced telehealth systems and wireless
remote Patient monitoring services. LifeWatch's services provide physicians
with critical information to determine appropriate treatment and thereby
improve Patient outcomes. LifeWatch AG has operative subsidiaries in the
United States, in Switzerland and in Israel, and is the parent company of
LifeWatch Services Inc., and LifeWatch Technologies, Ltd. LifeWatch
Services, Inc. is a leading U.S.-based provider of cardiac monitoring
services and home sleep testing of Obstructive Sleep Apnea (OSA). LifeWatch
Technologies Ltd., based in Israel, is a leading developer and manufacturer
of telemedicine products. For additional information, please visit
www.lifewatch.com.

Sign up for customized e-mail alerts and documentation requests at
http://www.irlifewatch.com/alert-service.aspx

This press release includes forward-looking statements. All statements
other than statements of historical facts contained in this press release,
including statements regarding future results of operations and financial
position, the business strategy, and plans and objectives for future
operations, are forward-looking statements. The words "believe," "may,"
"will," "estimate," "continue," "anticipate," "intend," "expect" and
similar expressions are intended to identify forward-looking statements.
LifeWatch AG has based these forward-looking statements largely on current
expectations and projections about future events and financial trends that
it believes may affect the financial condition, results of operations,
business strategy, short-term and long-term business operations and
objectives, and financial needs. These forward-looking statements are
subject to a number of risks, uncertainties and assumptions. In light of
these risks, uncertainties and assumptions, the forward-looking events and
circumstances described may not occur and actual results could differ
materially and adversely from those anticipated or implied in the
forward-looking statements. All forward-looking statements are based only
on data available to LifeWatch AG at the time of the issue of this press
release. LifeWatch AG does not undertake any obligation to update any
forward-looking statements contained in this press release as a result of
new information, future events or otherwise.

THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH
AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES, OR AN
INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH AG OR
ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE SECURITIES OF
LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER THE UNITED
STATES SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED WITHIN THE
UNITED STATES OR TO U.S. PERSONS ABSENT FROM REGISTRATION UNDER OR AN
APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED
STATES SECURITIES LAWS. ANY PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE
UNITED STATES WILL BE MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED
FROM LIFEWATCH AG OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN
DETAILED INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS
FINANCIAL STATEMENTS OF THE ISSUER.


16.10.2014 News transmitted by EQS Schweiz AG.
The issuer is responsible for the contents of the release.

EQS publishes regulatory releases, media releases on the capital
market and press releases.
The EquityStory Group distributes authentic and real-time financial news
for over 1'300 listed companies.
The Swiss news archive can be found at www.equitystory.ch/news

---------------------------------------------------------------------------

Language:               English
Company:                LifeWatch AG
                        Rundbuckstrasse 6
                        8212 Neuhausen am Rheinfall
                        Switzerland
Phone:                  +41 52 632 00 50
Fax:                    +41 52 632 00 51
E-mail:
Internet:            www.lifewatch.com
ISIN:                   CH0012815459
Valor:                  811189
Listed:                 Freiverkehr in Berlin, Stuttgart; Frankfurt in Open
                        Market ; SIX

End of Announcement                             EQS Group News-Service

---------------------------------------------------------------------------

Weitere Storys: LifeWatch AG
Weitere Storys: LifeWatch AG